Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FCHSD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | PMM2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | PPAN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SENP7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | C11orf68 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | RPRD1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | RP13-512J5.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | DOCK11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ASCL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | DAXX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |